http://www.canadiancapitalist.com/2q-2005-report-card/ Helping you invest and prosper Sat, 11 Feb 2012 19:27:54 +0000 hourly 1 http://wordpress.org/?v=3.3.1 http://www.canadiancapitalist.com/2q-2005-report-card/#comment-160 Anonymous Wed, 30 Nov -0001 00:00:00 +0000 http://www.canadiancapitalist.com/?p=219#comment-160 Why did NitroMed (NTMD) only increase 13% on news that it would begin sales of its drug BilDil by 7 July? Based on the market for Nitric Oxide drugs BilDil should bring sales of $220 million by 4Q 2005 and $550M by 3Q 2006. That would put NTMD's book value at $42/share. It is currently priced at $22/sh. Why is there such an unvaluation of this stock. Is it still undiscovered? Why did NitroMed (NTMD) only increase 13% on news that it would begin sales of its drug BilDil by 7 July? Based on the market for Nitric Oxide drugs BilDil should bring sales of $220 million by 4Q 2005 and $550M by 3Q 2006. That would put NTMD’s book value at $42/share. It is currently priced at $22/sh. Why is there such an unvaluation of this stock. Is it still undiscovered?

]]> http://www.canadiancapitalist.com/2q-2005-report-card/#comment-161 Arbee Wed, 30 Nov -0001 00:00:00 +0000 http://www.canadiancapitalist.com/?p=219#comment-161 Anon: I don't follow NTMD, so I don't have an opinion on it. Anon: I don’t follow NTMD, so I don’t have an opinion on it.

]]>